Effect of Heartfulness Meditation on Brain Waves and How Calm One Feels During Meditation

Status unconfirmed · Not applicable

Conditions studied: Anxiety, Stress

In brief

Objectives: 1. To assess the EEG patterns and EKG recordings of participants with no meditation experience with simply closing the eyes for 10 minutes followed by relaxing for 30 minutes. 2. To assess the EEG patterns and EKG recordings of participants with no meditation experience by simply closing the eyes for 10 minutes and then with guided Heartfulness relaxation and meditation for 30 minutes. 3. To assess the baseline anxiety score through GAD-7 questionnaire, subjective experience of all the participants through MEDEQ questionnaire that measures the depth of the meditation experience after the session and correlate with the EEG patterns of the brain and heart rate changes. EEG and EKG data from the groups will be analyzed by the sleep specialist. EKG device data for HRV and the EEG data will be correlated with the subjective depth of meditation experience in both the groups

Key facts

Study ID

NCT04721379

Run by

WellSpan Health

People needed

80

Starts

2021-07-31

Expected to finish

2023-02-15

Last updated by the study team

2021-10-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Adults above 18 years of age willing to participate in the study.

You may not qualify if…

• Participants unwilling to participate in the study and those with prior meditation experience.
• Participants who are unable to sit for 30 minutes due to either physical or mental conditions will be excluded.
• Participants with bipolar disorder, substance abuse (drugs or alcohol abuse in last 6 months), alcohol withdrawal, BMI < 18, suicidal ideation, active psychotherapy, major depression, anxiety disorder, obstructive sleep apnea, eating disorder, history of brain surgery or known brain tumors, known seizures or on treatment for seizures, borderline personality disorder, post-traumatic stress disorder, or psychotic disorder.
• Participants with known heart rhythm problems such as atrial fibrillation is advised not to participate.
• Participants on benzodiazepines or psychiatry medications, stimulants or sleeping pills that may potentially interfere with EEG patterns will be excluded.
• Participants on cardiovascular medications that affect the heart rate will be excluded.
• Participants who are unable to have the leads on their scalp or skin will be excluded.

Where it is running

• WellSpan Dover Sleep Center — Dover, Pennsylvania, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.